AMH Equity Ltd Trims Stock Holdings in Precision Optics Corp. $POCI

AMH Equity Ltd lowered its holdings in Precision Optics Corp. (NASDAQ:POCI) by 44.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 25,000 shares of the company’s stock after selling 20,000 shares during the period. AMH Equity Ltd’s holdings in Precision Optics were worth $122,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Needham Investment Management LLC boosted its holdings in Precision Optics by 63.7% in the first quarter. Needham Investment Management LLC now owns 700,000 shares of the company’s stock valued at $2,905,000 after purchasing an additional 272,500 shares during the last quarter. WealthTrust Axiom LLC boosted its holdings in Precision Optics by 2.7% in the first quarter. WealthTrust Axiom LLC now owns 253,909 shares of the company’s stock valued at $1,054,000 after purchasing an additional 6,629 shares during the last quarter. Finally, HighTower Advisors LLC boosted its holdings in Precision Optics by 34.9% in the first quarter. HighTower Advisors LLC now owns 96,565 shares of the company’s stock valued at $401,000 after purchasing an additional 25,000 shares during the last quarter. Hedge funds and other institutional investors own 13.71% of the company’s stock.

Precision Optics Trading Down 0.5%

Shares of NASDAQ POCI opened at $4.24 on Friday. The stock’s 50 day moving average price is $4.42 and its two-hundred day moving average price is $4.53. Precision Optics Corp. has a 52-week low of $3.47 and a 52-week high of $5.48. The stock has a market capitalization of $32.69 million, a P/E ratio of -5.05 and a beta of 0.36. The company has a quick ratio of 1.06, a current ratio of 1.64 and a debt-to-equity ratio of 0.11.

Precision Optics (NASDAQ:POCI) last announced its quarterly earnings data on Monday, September 29th. The company reported ($0.18) earnings per share (EPS) for the quarter. Precision Optics had a negative net margin of 30.28% and a negative return on equity of 51.33%. The firm had revenue of $6.18 million for the quarter. Precision Optics has set its FY 2026 guidance at EPS.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Precision Optics in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Precision Optics Company Profile

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.